Increased contrast enhancing lesion activity in relapsing–remitting multiple sclerosis migraine patients

Abstract

Our findings suggest an increased inflammatory pathobiology in MS patients with migraine headaches requiring possibly more frequent MRIs and also more efficient anti-inflammatory treatment.